Harborside

aleaf

Aleafia Health Inc

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

TORONTO, Sept. 16, 2022 -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted. Fo... Read More...
Aleafia Health Announces $12.0 Million Total Net Revenue in First Quarter, Representing a 13% Increase Over the Prior Year

Aleafia Health Announces $12.0 Million Total Net Revenue in First Quarter, Representing a 13% Increase Over the Prior Year

31% increase in branded cannabis net revenue1 to $10.0 million from $7.6 million in the prior year#12 ranking for market share in core markets2 for Q1 FY2023In the Ontario value category, Divvy has attained #5 market share in pre-roll and #7 in flower Secured new international partnership representing approximately $4.6 million sales comm... Read More...
Aleafia Health to Announce Fiscal Year 2023 First Quarter Results

Aleafia Health to Announce Fiscal Year 2023 First Quarter Results

TORONTO, Aug. 04, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on August 11 prior to market open its fiscal year 2023 first quarter results for the period ending June 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be ho... Read More...
Aleafia Health Announces Closing of Debenture Amendment Transaction

Aleafia Health Announces Closing of Debenture Amendment Transaction

TORONTO, June 28, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced amendment of its unsecured convertible debentures (the “Debenture Amendments”). “We are delighted we have now completed this transaction,” said Tricia Symmes Aleafia H... Read More...
Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5

Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5

151% increase in branded cannabis net revenue1 to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million in the prior 12-month year$8 million in branded cannabis net revenue for Q5, a growth of 55% calendar year over calendar year 3rd highest increase in overall market share rankings over ... Read More...
Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

TORONTO, June 24, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 28, 2022, prior to market open, its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will... Read More...
Aleafia Health Inc. Announces Closing of $5.6M Private Placement

Aleafia Health Inc. Announces Closing of $5.6M Private Placement

TORONTO, June 24, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) representing aggregate gross proceeds of approximately $5.6 million. Pursuant to the Private Placement, an aggregate of 68,... Read More...
Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

TORONTO, June 15, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 23 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be host... Read More...
Aleafia Health Announces Update Regarding Agreement to Amend Convertible Debentures and Equity Financing

Aleafia Health Announces Update Regarding Agreement to Amend Convertible Debentures and Equity Financing

Debentureholders representing approximately 61.4% of the Convertible Debentures outstanding have entered into Support Agreements1, including each member of the Steering Committee nominated by DebentureholdersCompany more than 90% towards achieving a minimum of 66 2/3% required to pass the Debenture AmendmentsDebentureholders of record as ... Read More...
Aleafia Health Implementing $6.7 Million in Annualized Cost Savings in 2022 and Reaffirms Guidance

Aleafia Health Implementing $6.7 Million in Annualized Cost Savings in 2022 and Reaffirms Guidance

$4.4 million annualized cost reductions being implemented in addition to $2.3 million announced in February 2022Grimsby, Ontario cultivation organization realigned to support anticipated growth in product throughputOrganizational realignment in the medical business to fully integrate the sales channelsCore corporate shared services consol... Read More...
Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth

Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth

Reached new record market share overall adult use market share of 2.06% in February 2022, advancing 33% from 1.54% in November 2021(1)Continued ascent in overall market share rankings, up two more notches to 13th in February 2022 from 15th in November 2021On the pathway towards a top 10 market share position by the end of 2022 Received fi... Read More...
Aleafia Health Reports Q4 2021 Financial Results with $11.5 Million Branded Cannabis Gross Revenue, representing a 103% Increase from 2020

Aleafia Health Reports Q4 2021 Financial Results with $11.5 Million Branded Cannabis Gross Revenue, representing a 103% Increase from 2020

Transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 202096% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in 202060% in... Read More...
Aleafia Health Appoints Tricia Symmes as CEO to Replace Geoffrey Benic

Aleafia Health Appoints Tricia Symmes as CEO to Replace Geoffrey Benic

TORONTO, Feb. 07, 2022 -- The Board of Directors of Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) today announced that CEO Geoffrey Benic will leave the Company, effective February 7, 2022. To succeed Benic, the Board named Tricia Symmes, previously the Company’s Chief Commercial Officer (CCO), as the Com... Read More...
Aleafia Health Provides Update on the Negotiation of its Convertible Debt

Aleafia Health Provides Update on the Negotiation of its Convertible Debt

TORONTO, Jan. 04, 2022 -- Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”). The Company has initiated negotiati... Read More...
Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

Credit Facility provides the Company with liquidity to fund operations and organic growth initiativesTwo-year term provides additional financial flexibility TORONTO, Dec. 29, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million ... Read More...
Aleafia Health to Announce 2021 Third Quarter Results

Aleafia Health to Announce 2021 Third Quarter Results

TORONTO, Nov. 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 third quarter results on November 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt S... Read More...
Aleafia Health Announces Appointment of David Pasieka to Board of Directors

Aleafia Health Announces Appointment of David Pasieka to Board of Directors

TORONTO, Sept. 01, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the appointment of David Pasieka to its board of directors. Mr. Pasieka is a seasoned public company executive and director with extensive board level experience in finance & audit, risk management, and ESG... Read More...
Aleafia Health Reports Strong 2021 Second Quarter Financial Results with 53% Sequential Increase in Cannabis Net Revenue

Aleafia Health Reports Strong 2021 Second Quarter Financial Results with 53% Sequential Increase in Cannabis Net Revenue

Adult-use cannabis net revenue increased 87% compared to the prior quarterMedical cannabis net revenue increased 23% compared to the prior quarter13 additional product SKUs released across multiple product formatsFor the first time, medical cannabis product was made available for sale in GermanyCommenced onboarding of medical cannabis pat... Read More...
Aleafia Health to Announce 2021 Second Quarter Results

Aleafia Health to Announce 2021 Second Quarter Results

TORONTO, Aug. 04, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 second quarter results on August 12, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sa... Read More...
Aleafia Health Announces the Appointment of Mark J. Sandler as Board Chair

Aleafia Health Announces the Appointment of Mark J. Sandler as Board Chair

TORONTO, July 29, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) a global leader in cannabis wellness products and services, is pleased to announce the appointment of Mark J. Sandler as Chairman of its Board of Directors (the “Board”). He is the longest serving member of the Company’s board, which ... Read More...
Aleafia Health Expands Bogart's Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

TORONTO, June 24, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced the expansion of its cannabis edibles portfolio with the first of its kind of Salted Caramel Pretzel Bites. The new format is now available and sold under th... Read More...
Aleafia Health Appoints Finance Executive Matt Sale as Chief Financial Officer

Aleafia Health Appoints Finance Executive Matt Sale as Chief Financial Officer

TORONTO, June 21, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce the appointment of Matt Sale to its executive leadership team as chief financial officer, effective today. Mr. Sale is a proven finance professional w... Read More...
Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET

Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET

TORONTO, June 15, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced that CEO Geoffrey Benic will participate in the Cantor Fitzgerald Canadian LPs Cannabis Forum on June 16. Wednesday, June 1610:00 a.m. ETRegistration Link For Investor & Media Relations Nicholas Bergamini, VP Inve... Read More...
Aleafia Health's Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

Aleafia Health’s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

TORONTO, June 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced the continued expansion of its dried flower portfolio with the launch of four new large format offerings under its everyday cannabis brand Divvy. The new products strengthen the existing Divvy portfolio following a su... Read More...
Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany

Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany

TORONTO, June 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that dried flower grown at its Niagara greenhouse facility has been successfully exported to Germany. Gaining access to Europe’s most mature legal can... Read More...
Aleafia Health to Present at Canaccord Genuity's Global Cannabis Conference on May 11, 2021

Aleafia Health to Present at Canaccord Genuity’s Global Cannabis Conference on May 11, 2021

TORONTO, May 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that CEO Geoffrey Benic will present at Canaccord Genuity’s Global Cannabis Conference on Tuesday, May 11, 2021 at 11:00 a.m. EDT. Participants can acc... Read More...
Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.

Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.

TORONTO, May 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its wholly-owned subsidiaries, Canabo Medical Corporation (“Canabo”) and GrowWise Health Limited (“GrowWise”), (together the “Vendors”) have closed a transaction (the “Transaction”) with Myconic Capital Corp... Read More...
Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

TORONTO, May 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human senso... Read More...